Securities code: 002382 securities abbreviation: Blue Sail Medical Co.Ltd(002382) bond Code: 128108 bond abbreviation: lanfan convertible bond
Blue Sail Medical Co.Ltd(002382)
Simplified equity change report
Name of listed company: Blue Sail Medical Co.Ltd(002382) stock listing place: Shenzhen Stock Exchange Stock abbreviation: Blue Sail Medical Co.Ltd(002382) Stock Code: 002382 information disclosure obligor: Beijing Xinyu Investment Center (limited partnership) domicile: floor 10 (1008b), No. 33 Dengshikou street, Dongcheng District, Beijing communication address: floor 10 (1008b), No. 33 Dengshikou street, Dongcheng District, Beijing Nature of share change: share decrease signing date: January 2002
Statement of information disclosure obligor
1、 This report is in accordance with the securities law of the people’s Republic of China (hereinafter referred to as the “Securities Law”) and the measures for the administration of the acquisition of listed companies (hereinafter referred to as the “measures for the administration of acquisition”) Standards for the contents and forms of information disclosure by companies offering securities to the public No. 15 – Report on changes in equity (hereinafter referred to as “Standards No. 15”) and preparation of relevant laws, regulations and normative documents.
2、 The information disclosure obligor has obtained necessary authorization and approval for signing this equity change report, and its performance does not violate or conflict with any provision in the internal provisions of the information disclosure obligor.
3、 In accordance with the provisions of the securities law, the measures for the administration of acquisitions, the Standards No. 15 and other regulations, this equity change report has fully disclosed the changes in shares in Blue Sail Medical Co.Ltd(002382) (hereinafter referred to as “the company”, “listed company” or ” Blue Sail Medical Co.Ltd(002382) “) owned by the information disclosure obligor; As of the signing date of this report, except for the information disclosed in this report, the above information disclosure obligor has not increased or reduced its shares in Blue Sail Medical Co.Ltd(002382) by any other means.
4、 This equity change is based on the information stated in this equity change report. Except for the information disclosure obligor, no other person has been entrusted or authorized to provide the information not listed in the equity change report and make any explanation or explanation to the report.
5、 The information disclosure obligor undertakes that there are no false records, misleading statements or major omissions in this equity change report, and shall bear individual and joint legal liabilities for its authenticity, accuracy and completeness.
catalogue
The disclosure obligor declares that 2 catalog Section 1 interpretation Section 2 Introduction to information disclosure obligors Section III purpose of equity change Section IV equity change method 8 section V Trading of listed shares in the first six months Section VI other major matters Section VII declaration of information disclosure obligor Section VIII documents for future reference 13 attached table: simplified equity change report fourteen
Section I interpretation
In this report, unless otherwise specified, the following abbreviations have the following meanings:
This equity change report / this report refers to the Blue Sail Medical Co.Ltd(002382) simplified equity change report
Company / listed company / Blue Sail Medical Co.Ltd(002382) refers to Blue Sail Medical Co.Ltd(002382) , which is listed on Shenzhen Stock Exchange, stock code: 002382
Information disclosure obligor / Beijing Xinyu refers to Beijing Xinyu Investment Center (limited partnership)
Blue Sail Medical Co.Ltd(002382) the convertible bonds of 3.144 billion convertible companies publicly issued in 2020 were converted into shares, and the convertible bonds into shares refers to bonds (bonds referred to as “lanfan convertible bonds”, bond Code: 128108) entered the conversion period on December 3, 2020, and the bondholders carried out the conversion
Beijing Xinyu sold its Blue Sail Medical Co.Ltd(002382) 31541374 shares through block trading and centralized bidding; Beijing Xinyu passively diluted its shareholding ratio due to the conversion of convertible bond holders; This equity change / transaction in Beijing means that Xinyu will reduce the company’s shares held by the listed company by 24787109 shares due to the repurchase and cancellation of performance commitment compensation shares (share nature: restricted shares). The above equity changes with the proportion of active reduction and passive dilution of shares reaching 5%
Securities Law means the securities law of the people’s Republic of China
The measures for the administration of acquisitions refer to the measures for the administration of acquisitions of listed companies
The current effective laws, regulations, rules or other normative laws and regulations of China, including their modification, amendment, supplement, interpretation or re enactment from time to time
CSRC / CSRC means China Securities Regulatory Commission
Shenzhen stock exchange refers to Shenzhen Stock Exchange
Yuan, ten thousand yuan and one hundred million yuan refer to RMB yuan, ten thousand yuan and one hundred million yuan
Note: any discrepancy between the total and the mantissa of the sum of the sub item values in this report is caused by rounding.
Section II introduction to information disclosure obligors
1、 Basic information of information disclosure obligor
1. Basic information
Name: Beijing Xinyu Investment Center (limited partnership)
Unified social credit code 911101015885624h
Enterprise type: limited partnership
Executive partner Beijing Yude Investment Management Center (limited partnership)
Industrial and Commercial Registration No.: 110101014370304
Registered capital-
Date of establishment: October 28, 2011
Business term: October 28, 2011 to no fixed term
Registered address: floor 10 (1008b), No. 33, Dengshikou street, Dongcheng District, Beijing
Project investment; Investment management; Investment consulting.
（ “1. No fund shall be raised in public without the approval of relevant departments; 2. No trading activities of securities products and financial derivatives shall be carried out in public; 3. No loans shall be granted; 4. No guarantee shall be provided for the business scope of enterprises other than the invested enterprises; 5. No commitment to invest in the company shall be made to investors “No loss or commitment of minimum return”; Market entities independently choose business projects and carry out business activities according to law; For projects subject to approval according to law, business activities shall be carried out according to the approved contents after being approved by relevant departments; It is not allowed to engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this Municipality.)
Major shareholder China Life Insurance Company Limited(601628) , National Social Security Fund Council, Beijing state owned capital operation and Management Center
Tel: 010-85079001
2. Basic information of information disclosure obligor and executive partner
Name: Beijing Yude Investment Management Center (limited partnership)
Unified social credit code 91110101585840418e
Enterprise type: limited partnership
Executive partner Shanghai pannuo Enterprise Management Service Co., Ltd
Industrial and Commercial Registration No.: 110101014335648
Registered capital: 10.9975 million yuan
Date of establishment: October 17, 2011
Business term: October 17, 2011 to no fixed term
Registered address: room 539A, No. 17, houyongkang Hutong, Dongcheng District, Beijing
Investment management; Investment consulting. (the enterprise shall independently select business items and carry out business activities according to law; for the items whose business scope must be approved according to law, it shall carry out business activities according to the approved contents after being approved by relevant departments; it shall not engage in business activities of items prohibited and restricted by the industrial policies of this city.)
Major shareholders: Shanghai Yude equity investment center (limited partnership) and Shanghai pannuo Enterprise Management Service Co., Ltd
Tel: 010-85079000
3. Basic information of directors and main responsible persons of information disclosure obligors
Have you obtained the right of residence in other countries’ names, gender, position, nationality, long-term residence home / region
Tian Yunan appointed representative Beijing, China
2、 Information disclosure obligor’s equity shares in other domestic and overseas listed companies reach or exceed 5% of the issued shares of the company
As of the signing date of this report, the shares of Beijing Xinyu in other domestic and overseas listed companies have reached or exceeded 5% of the issued shares of the company as follows:
No. company name stock shareholding ratio
code
1. Beikong clean energy hk01250 11.9557% (excluding options)
2 Shanghai Zj Bio-Tech Co.Ltd(688317) 688317 20.2600% (held through Panxin (Shanghai) Equity Investment Center (limited partnership))
3 Weihai Guangwei Composites Co.Ltd(300699) 300699 8.6554%
Section III purpose of equity change
1、 Purpose of this equity change
1. Due to its own capital needs, the information disclosure obligor reduces its shares in the company through block trading and centralized bidding trading.
2. The information disclosure obligor passively diluted the shareholding ratio due to the conversion of convertible corporate bonds issued by the company in 2020;
3. The information disclosure obligor is the performance commitment Party of the company’s major asset restructuring, and its shareholding is reduced due to the company’s repurchase and cancellation of performance commitment compensation shares.
2、 Arrangements for information disclosure obligors to increase or reduce their equity shares in Listed Companies in the next 12 months
1. On September 4, 2021, the company disclosed the announcement on the pre disclosure of the future reduction plan of shareholders holding more than 5% (Announcement No.: 2021-084) on the designated information disclosure media, Beijing Xinyu, a shareholder holding more than 5%, plans to reduce its total shares of the company by block trading within 6 months after three trading days from the date of announcement and disclosure, and to reduce its total shares of the company by centralized bidding within 6 months after 15 trading days, The total amount shall not exceed 6% of the total share capital of the company.
